Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000563184 | SCV000663778 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000648272 | SCV000770086 | likely benign | Fanconi anemia complementation group O | 2024-05-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000563184 | SCV001358175 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506381 | SCV002809143 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 3; Fanconi anemia complementation group O | 2022-01-12 | criteria provided, single submitter | clinical testing |